Spots Global Cancer Trial Database for clr 131
Every month we try and update this database with for clr 131 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma | NCT03478462 | Pediatric Solid... Pediatric Lymph... Pediatric Brain... DIPG Neuroblastoma Ewing Sarcoma Rhabdomyosarcom... Osteosarcoma | CLR 131 | 2 Years - 25 Years | Cellectar Biosciences, Inc. | |
Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG | NCT05610891 | High-Grade Glio... | CLR 131 | 10 Years - 25 Years | Cellectar Biosciences, Inc. | |
CLR 131 Combined With Radiation for Head and Neck Cancer | NCT04105543 | Head and Neck C... | CLR 131 | 18 Years - | University of Wisconsin, Madison | |
CLR 131 Combined With Radiation for Head and Neck Cancer | NCT04105543 | Head and Neck C... | CLR 131 | 18 Years - | University of Wisconsin, Madison |